Matthew Lyall, BSc

Associate, Market Access and Outcomes Strategy

BSc (hons), Biomedical Science

The University of Manchester, Manchester, UK

Matthew Lyall, BSc, works as a Health Outcomes Scientist at RTI-HS in the Manchester office. Mr. Lyall joined RTI-HS as an intern and prior to joining RTI-HS, he completed an honors Bachelors of Science degree in Biomedical Sciences. While getting his degree, Mr. Lyall completed a lab-based research project in the Manchester Collaborative Centre for Inflammation Research. In this project, he contributed to cutting edge research that helped determine how a protein involved in initiating the inflammatory process is regulated by ubiquitination. Mr. Lyall has experience in contributing to systematic and targeted literature reviews, evidence based value dossiers, slide sets, communication packages, and submissions. Mr. Lyall has been involved in projects in a range of therapeutic areas, including oncology, diabetes, age-related macular degeneration, asthma, multiple sclerosis, Alzheimer’s disease and cytomegalovirus infection.